Advertisement

Psychopharmacologia

, Volume 9, Issue 1, pp 48–63 | Cite as

Metabolic fate of mescaline in man

  • K. D. Charalampous
  • K. E. Walker
  • John Kinross-Wright
Original Investigations

Summary

Human subjects given C14-mescaline by mouth excrete an average of 87% of the dose during the first 24 hours and an average of 92% during the first 48 hours. Average half-life of mescaline in six hours.

The composition of the urine in respect to the various metabolites of mescaline from hour to hour has been determined. The concentration of mescaline and its metabolites in the plasma and the cerebrospinal fluid at the various times has also been determined.

Mescaline, 3,4,5-trimethoxyphenylacetic acid, N-acetyl-β-(3,4-dimethoxy-5-hydroxyphenyl) ethylamine and N-acetyl-mescaline have been identified in human urine after mescaline administration in the following amounts: mescaline 55–60%, 3,4,5-trimethoxyphenylacetic acid 27–30%, N-acetyl-β-(3,4,dimethoxy-5-hydroxyphenyl) ethylamine 5% and N-acetylmescaline less than 0.1%. Five other metabolites have been partially characterized.

Chromatographic evidence is presented for the presence of mescaline, 3,4,5-trimethoxyphenylacetic acid, N-acetylmescaline and N-acetyl-β-(3,4-dimethoxy-5-hydroxyphenyl) ethylamine in the cerebrospinal fluid in man after oral mescaline administration.

Keywords

Cerebrospinal Fluid Human Subject Human Urine Metabolic Fate Ethylamine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baillie, L. A.: Determination of liquid scintillation counting efficiency by pulse height shift. Int. J. appl. Radiat. 8, 1–7 (1960).Google Scholar
  2. Block, W., K. Block u. B. Patzig: Zur Physiologie des 14C-radioaktiven Mescalins im Tierversuch. III. Mitteilung. Mescalineinbau in Leberprotein. Hoppe-Seylers Z. physiol. Chem. 291, 119–218 (1952).Google Scholar
  3. —: Zur Physiologie des 14C-radioaktiven Mescalins im Tierversuch. IV. Mitt. Vergleichende Untersuchungen mit 14C-Mescalin und 14C-β-phenyl-äthylamin. Z. Naturforsch. 8b, 440, 444 (1953).Google Scholar
  4. Charalampous, K. D., and J. Kinross-Wright: Hallucinogens, tools for research or therapeutic agents. Tex. St. J. Med. 59, 848–852 (1963).Google Scholar
  5. —, A. Orengo, K. E. Walker, and J. Kinross-Wright: Metabolic fate of β-(3,4,5-trimethoxyphenyl)-ethylamine (Mescaline) in humans: isolation and identification of 3,4,5-trimethoxy-phenylacetic acid. J. Pharmacol. exp. Ther. 145, 242–246 (1964).Google Scholar
  6. Downing, D. F.: The chemistry of psychotomimetic substances. Quart. Rev. (Lond.) 16, 133–162 (1962).Google Scholar
  7. Fischer, R.: Pharmacology and metabolism of mescaline. Rev. canad. Biol. 17, 389–409 (1958).Google Scholar
  8. Giarman, N. J., and D. X. Freedman: Biochemical aspects of the actions of psychotomimetic drugs. Pharmacol. Rev. 17, 1–25 (1965).Google Scholar
  9. Jacobsen, E.: The clinical pharmacology of the hallucinogens. Clin. Pharmacol. Ther. 4, 480–503 (1963).Google Scholar
  10. Kalberer, F., u. U. J. Rutschmann: Eine Schnellmethode zur Bestimmung von Tritium, Radiokohlenstoff und Radioschwefel in beliebigem organischem Probematerial mittels des Flüssigkeits-scintillations-Zählers. Helv. chim. Acta 44, 1956–1966 (1961).Google Scholar
  11. Lajtha, A.: Biochemistry of hallucinogens. In: Psychopharmacology, pharmacologic effects on behavior. Edited by Pennes, H. H. New York: Hoeber 1958.Google Scholar
  12. Mokrasch, L. C., and I. Stevenson: The metabolism of mescaline with a note on correlations between metabolism and psychological effects. J. nerv. ment. Dis. 129, 177–183 (1959).Google Scholar
  13. Neff, N., G. V. Rossi, G. D. Chase, and J. L. Rabinowitz: Distribution and metabolism of mescaline-C14in the cat brain. J. Pharmacol. exp. Ther. 144, 1–7 (1964).Google Scholar
  14. Rinkel, M.: The presidential address: the LSD movement in America. Paper read at Soc. Biol. Psychiat., New York City, April–May, 1965.Google Scholar
  15. Slotta, K. H., u. J. Müller: Über den Abbau des Mescalins und mescalinähnlicher Stoffe im Organismus. Hoppe-Seylers Z. physiol. Chem. 238, 14–22 (1936).Google Scholar
  16. Smith, A. A., and S. B. Wortis: Formation and metabolism of N-acetylnormetanephrine in the rat. Biochim. biophys. Acta (Amst.) 60, 420–422 (1962).Google Scholar
  17. Weissbach, H., B. G. Redfield, and J. Axelrod: The enzymic acetylation of serotonin and other naturally occurring amines. Biochim. biophys. Acta (Amst.) 54, 190–192 (1962).Google Scholar

Copyright information

© Springer-Verlag 1966

Authors and Affiliations

  • K. D. Charalampous
    • 1
    • 2
  • K. E. Walker
    • 1
    • 2
  • John Kinross-Wright
    • 1
    • 2
  1. 1.Department of PsychiatryBaylor University College of MedicineUSA
  2. 2.Houston State Psychiatric InstituteUSA

Personalised recommendations